Measles-containing-vaccine second-dose (MCV2) immunization coverage in High income (World Bank)

High income (World Bank): Measles-containing-vaccine second-dose (MCV2) immunization coverage was 91.0% in 2025. ▲ Rising

Latest (2025)
91.0%
Change on year
unchanged
Rank
2nd
of 11 groups
All-time high
93.0%
in 2018
All-time low
47.0%
in 2000
Years of data
26
2000–2025

Measles-containing-vaccine second-dose (MCV2) immunization coverage in High income (World Bank), 2000–2025

0204060801002000201220252000: 472001: 542002: 612003: 622004: 682005: 692006: 702007: 702008: 772009: 782010: 832011: 832012: 862013: 902014: 912015: 912016: 922017: 922018: 932019: 932020: 922021: 922022: 922023: 912024: 912025: 91

Source: World Health Organization, Global Health Observatory.

Analysis

High income (World Bank) recorded 91.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.

That represents a change of unchanged over ten years.

Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in High income (World Bank) peaked at 93.0% in 2018 and was at its lowest, 47.0%, in 2000.

The long-run direction has been consistently rising across the 26 years of available data.

Measles-containing-vaccine second-dose (MCV2) immunization coverage in High income (World Bank), year by year

Annual values for Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC) in High income (World Bank), 2000 to 2025.
Year Value Change
2000 47.0%
2001 54.0% +14.9%
2002 61.0% +13.0%
2003 62.0% +1.6%
2004 68.0% +9.7%
2005 69.0% +1.5%
2006 70.0% +1.4%
2007 70.0% +0.0%
2008 77.0% +10.0%
2009 78.0% +1.3%
2010 83.0% +6.4%
2011 83.0% +0.0%
2012 86.0% +3.6%
2013 90.0% +4.7%
2014 91.0% +1.1%
2015 91.0% +0.0%
2016 92.0% +1.1%
2017 92.0% +0.0%
2018 93.0% +1.1%
2019 93.0% +0.0%
2020 92.0% -1.1%
2021 92.0% +0.0%
2022 92.0% +0.0%
2023 91.0% -1.1%
2024 91.0% +0.0%
2025 91.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 65.6% 47.0% 78.0% 10
2010s 89.4% 83.0% 93.0% 10
2020s 91.5% 91.0% 92.0% 6

Countries ranked near High income (World Bank)

  1. 1 Uzbekistan 99.0% compare
  2. 1 Saudi Arabia 99.0% compare
  3. 1 Bhutan 99.0% compare
  4. 1 Maldives 99.0% compare
  5. 1 Korea, Democratic People's Republic of 99.0% compare
  6. 1 Palestine, State of 99.0% compare
  7. 1 Bahrain 99.0% compare
  8. 1 Hungary 99.0% compare
  9. 1 Niue 99.0% compare
  10. 1 Brunei Darussalam 99.0% compare
  11. 1 Oman 99.0% compare
  12. 1 Cuba 99.0% compare
  13. 1 Saint Vincent and the Grenadines 99.0% compare
  14. 1 Qatar 99.0% compare
  15. 1 Turkmenistan 99.0% compare

See the full ranking of 207 places →

More health data for High income (World Bank)

All data for High income (World Bank) →

Frequently asked questions

What is measles-containing-vaccine second-dose (mcv2) immunization coverage in High income (World Bank)?
Measles-containing-vaccine second-dose (mcv2) immunization coverage in High income (World Bank) was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in High income (World Bank)?
The highest recorded value was 93.0% in 2018.
What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in High income (World Bank)?
The lowest recorded value was 47.0% in 2000.
How does High income (World Bank) rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
High income (World Bank) ranks 2nd out of 11 groups with data for 2025.
Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in High income (World Bank)?
Over the last ten years it is unchanged. The long-run trend across the full record is rising.
Where does this High income (World Bank) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Measles-containing-vaccine second-dose (MCV2) immunization coverage in High income (World Bank). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 04 September 2026, from https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/high-income-world-bank/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/high-income-world-bank/">Measles-containing-vaccine second-dose (MCV2) immunization coverage in High income (World Bank)</a> — Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 5,363 data points, 2000–2025
Last refreshed